Brief report: Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: A clinical trial

Stephen Bent, Kiah Bertoglio, Paul Ashwood, Edward Nemeth, Robert L. Hendren

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We sought to determine whether HBOT leads to parental reported behavioral changes and alterations in cytokines in children with ASD. Ten children completed 80 sessions of HBOT and all improved by 2 points on the clinician-rated CGI-I scale (much improved) as well as several parent-completed measures of behavior. The lack of a control group limits the ability to determine if improvements were related to HBOT. Enrolled children did not exhibit abnormal cytokine levels at baseline and no significant changes in mean cytokine levels were observed. Although this study was limited by the small sample size and by the variable nature of cytokines, we found no evidence that HBOT affects cytokine levels or that cytokine levels were associated with behavioral changes.

Original languageEnglish (US)
Pages (from-to)1127-1132
Number of pages6
JournalJournal of Autism and Developmental Disorders
Volume42
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Hyperbaric Oxygenation
Clinical Trials
Cytokines
Aptitude
Sample Size
Autism Spectrum Disorder
Control Groups

Keywords

  • Alternative therapy
  • Autism
  • Clinical trial

ASJC Scopus subject areas

  • Developmental and Educational Psychology

Cite this

Brief report : Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: A clinical trial. / Bent, Stephen; Bertoglio, Kiah; Ashwood, Paul; Nemeth, Edward; Hendren, Robert L.

In: Journal of Autism and Developmental Disorders, Vol. 42, No. 6, 06.2012, p. 1127-1132.

Research output: Contribution to journalArticle

Bent, Stephen ; Bertoglio, Kiah ; Ashwood, Paul ; Nemeth, Edward ; Hendren, Robert L. / Brief report : Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: A clinical trial. In: Journal of Autism and Developmental Disorders. 2012 ; Vol. 42, No. 6. pp. 1127-1132.
@article{0f1e437a62504016b8150718610c2d4d,
title = "Brief report: Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: A clinical trial",
abstract = "We sought to determine whether HBOT leads to parental reported behavioral changes and alterations in cytokines in children with ASD. Ten children completed 80 sessions of HBOT and all improved by 2 points on the clinician-rated CGI-I scale (much improved) as well as several parent-completed measures of behavior. The lack of a control group limits the ability to determine if improvements were related to HBOT. Enrolled children did not exhibit abnormal cytokine levels at baseline and no significant changes in mean cytokine levels were observed. Although this study was limited by the small sample size and by the variable nature of cytokines, we found no evidence that HBOT affects cytokine levels or that cytokine levels were associated with behavioral changes.",
keywords = "Alternative therapy, Autism, Clinical trial",
author = "Stephen Bent and Kiah Bertoglio and Paul Ashwood and Edward Nemeth and Hendren, {Robert L.}",
year = "2012",
month = "6",
doi = "10.1007/s10803-011-1337-3",
language = "English (US)",
volume = "42",
pages = "1127--1132",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Brief report

T2 - Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: A clinical trial

AU - Bent, Stephen

AU - Bertoglio, Kiah

AU - Ashwood, Paul

AU - Nemeth, Edward

AU - Hendren, Robert L.

PY - 2012/6

Y1 - 2012/6

N2 - We sought to determine whether HBOT leads to parental reported behavioral changes and alterations in cytokines in children with ASD. Ten children completed 80 sessions of HBOT and all improved by 2 points on the clinician-rated CGI-I scale (much improved) as well as several parent-completed measures of behavior. The lack of a control group limits the ability to determine if improvements were related to HBOT. Enrolled children did not exhibit abnormal cytokine levels at baseline and no significant changes in mean cytokine levels were observed. Although this study was limited by the small sample size and by the variable nature of cytokines, we found no evidence that HBOT affects cytokine levels or that cytokine levels were associated with behavioral changes.

AB - We sought to determine whether HBOT leads to parental reported behavioral changes and alterations in cytokines in children with ASD. Ten children completed 80 sessions of HBOT and all improved by 2 points on the clinician-rated CGI-I scale (much improved) as well as several parent-completed measures of behavior. The lack of a control group limits the ability to determine if improvements were related to HBOT. Enrolled children did not exhibit abnormal cytokine levels at baseline and no significant changes in mean cytokine levels were observed. Although this study was limited by the small sample size and by the variable nature of cytokines, we found no evidence that HBOT affects cytokine levels or that cytokine levels were associated with behavioral changes.

KW - Alternative therapy

KW - Autism

KW - Clinical trial

UR - http://www.scopus.com/inward/record.url?scp=84863866614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863866614&partnerID=8YFLogxK

U2 - 10.1007/s10803-011-1337-3

DO - 10.1007/s10803-011-1337-3

M3 - Article

C2 - 21818676

AN - SCOPUS:84863866614

VL - 42

SP - 1127

EP - 1132

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 6

ER -